Duration of Face Down Positioning for Full-Thickness Macular Hole Repair

Sponsor
St. Joseph's Healthcare Hamilton (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06000111
Collaborator
(none)
40
2
16.6

Study Details

Study Description

Brief Summary

A full-thickness macular hole is when there is a small gap that opens in the center part of the retina (the light-sensitive layer of tissue in the back of the eye). Following surgical repair of these holes, patients have to lie face down for a number of days and nights. The exact amount of time necessary to position is however unknown. The goal of this randomized feasibility clinical trial is to compare 3 days and nights of face-down positioning to 7 days and nights of face-down positioning following pars plana vitrectomy surgery for full-thickness macular holes on key patient outcomes. This study will be a feasibility study to better inform a future larger clinical trial. Additionally, this investigation will be examining the rates of macular hole closure, patient visual acuity following surgery, patient quality of life, patient compliance, and complication rates.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: 3 Days of face-down positioning
  • Behavioral: 7 Days of face-down positioning
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This study will be a single-centered, parallel group randomized controlled feasibility trial. Patients will be randomized 1:1 between groups.This study will be a single-centered, parallel group randomized controlled feasibility trial. Patients will be randomized 1:1 between groups.
Masking:
Single (Outcomes Assessor)
Masking Description:
The surgeon will be masked to the patient's treatment allocation until after surgery is complete. At this point, the surgeon will be made aware of the patient's treatment allocation and inform the patient in the recovery room regarding their treatment allocation. The participants and the clinical teams managing the patient care will be unmasked. The outcome assessors will be masked.
Primary Purpose:
Treatment
Official Title:
Duration of Face Down Positioning Following Full-Thickness Macular Hole Repair: A Randomized Feasibility Study
Anticipated Study Start Date :
Aug 15, 2023
Anticipated Primary Completion Date :
May 15, 2024
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Face-Down Positioning for 3-Days and Nights

Patients allocated to this study arm will maintain face-down positioning for 3-days and nights post-operatively. Patients will be advised to posture immediately following surgery and will be advised to posture for 50 minutes of each hour. Patients will be advised that during their 10-minute break each hour, they should avoid face-up positioning. FDP will be advised during both waking and sleeping hours.

Behavioral: 3 Days of face-down positioning
Following surgical repair, patients in the intervention group will maintain 3-days and nights of face-down positioning post-operatively.

Active Comparator: Face-Down Positioning for 7-Days and Nights

Patients allocated to this study arm will maintain face-down positioning for 7-days and nights post-operatively. Patients will be advised to posture immediately following surgery and will be advised to posture for 50 minutes of each hour. Patients will be advised that during their 10-minute break each hour, they should avoid face-up positioning. FDP will be advised during both waking and sleeping hours.

Behavioral: 7 Days of face-down positioning
Following surgical repair, patients in the intervention group will maintain 7-days and nights of face-down positioning post-operatively.

Outcome Measures

Primary Outcome Measures

  1. Recruitment Rate [The recruitment rate will be calculated during the recruitment period.]

    This investigation's primary objective will be focused on assessing feasibility. One primary outcome will be to evaluate the recruitment rate of this study.

  2. Retention Rate [The retention rate will be calculated at 3-months post-operatively.]

    This investigation's primary objective will be focused on assessing feasibility. One primary outcome will be to evaluate the retention rate of this study.

  3. Completion Rate [The completion rate will be calculated at 3-months post-operatively.]

    This investigation's primary objective will be focused on assessing feasibility. One primary outcome will be to evaluate the completion rate of this study.

  4. Recruitment Time [The recruitment time will be calculated during the recruitment period.]

    This investigation's primary objective will be focused on assessing feasibility. One primary outcome will be to evaluate the recruitment time for this study.

Secondary Outcome Measures

  1. Macular Hole Closure Rate [3-months post-operatively]

    The rate of macular hole closure will be evaluated by 2-independent readers masked to treatment allocation. They will grade the outcome as open or closed. Outcomes classified as open will be further divided into open and flat (without a cuff of subretinal fluid) or open and elevated (with a cuff of subretinal fluid).

  2. Best-Corrected Visual Acuity (BCVA) [3-months post-operatively]

    Patient best-corrected visual acuity will be measured by Early Treatment Diabetic Retinopathy Study (ETDRS) letter score.

  3. Vision specific quality of life measure [3-months post-operatively]

    The National Eye Institute Visual Function Questionnaire (NEI VFQ-25) will be administered to patients. Possible patient scores range from 0 to 100 with a higher score representing higher vision-related quality of life.

  4. Compliance with Face Down Positioning [While the patient is positioning; this will either be for 3 days or 7 days depending on their treatment allocation.]

    Compliance will be assessed with self-administered questionnaires three times per day during the duration of positioning. The possible range of scores is from 1 to 10 with higher scores indicating better compliance.

  5. Complication Rates [Rates will be determined for the entire follow-up period (3-months)]

    Specifically, the rates of endophthalmitis, retinal detachment, and vitreous hemorrhage

  6. Health Related Quality of Life Measure [3-months post-operatively]

    The Quality of Life Scale (QOLS) will be administered to patients. The range of possible patient scores is from 16 to 112. Higher scores indicate higher quality of life.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Consecutive patients with an idiopathic full-thickness macular hole

  • Symptom duration of less than 6 months

  • Patient must agree to participate in this investigation

Exclusion Criteria:
  • Macular hole minimum diameter >1000 μm

  • A history of high myopia (> -6)

  • Traumatic macular hole

  • Amblyopia

  • Retinal vein occlusion

  • Inflammatory eye diseases

  • Patients found to have a retinal tear during either the pre-operative assessment or intraoperatively

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • St. Joseph's Healthcare Hamilton

Investigators

  • Principal Investigator: Varun Chaudhary, MD, FRCSC, McMaster University, St. Joseph's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Varun Chaudhary, Professor, Department of Surgery, Chief of Ophthalmology, Hamilton Regional Eye Institute, St. Joseph's Healthcare Hamilton
ClinicalTrials.gov Identifier:
NCT06000111
Other Study ID Numbers:
  • 16100
First Posted:
Aug 21, 2023
Last Update Posted:
Aug 21, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 21, 2023